TETRACYCLINE COMPOUNDS

DE602013086620T2Inactive Publication Date: 2025-03-26TETRAPHASE PHARMACEUTICALS INC
0 Cites 0 Cited by

Patent Information

Application Number
DE602013086620
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2012-08-31
Filing Date
2013-08-30
Publication Date
2025-03-26
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The widespread use of tetracyclines in medicine has led to the emergence of resistance among bacterial species, necessitating the development of new tetracycline analogs with improved antibacterial activities and efficacies against tetracycline-responsive diseases or disorders.

Method used

A compound represented by Structural Formula (I) or its pharmaceutically acceptable salt, which can be used in pharmaceutical compositions for treating and preventing bacterial infections, is disclosed. This compound has various substituents that can form carbocyclyl or heterocyclyl rings, offering enhanced antibacterial properties.

Benefits of technology

The compound demonstrates improved antibacterial activities against resistant bacterial strains and is effective in treating a range of tetracycline-responsive diseases, including infections and inflammatory disorders, while minimizing resistance development.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.